Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab for Diabetic Retinopathy
NCT00600262Phase 3Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Dec 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in diabetic retinopathy (DR), sponsored by Asociación para Evitar la Ceguera en México. Started Dec 2005; status: terminated.
02
Drugs
bevacizumab
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT00600262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600262.